The state of Maryland currently has 16 active clinical trials seeking participants for Migraine research studies. These trials are conducted in various cities, including Baltimore, Bethesda, Rockville and Annapolis.
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
Recruiting
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Gender:
ALL
Ages:
Between 6 years and 17 years
Trial Updated:
01/20/2025
Locations: Pharmasite Research, Inc., Baltimore, Maryland
Conditions: Migraine
Family Study of Affective and Anxiety Spectrum Disorders
Recruiting
This study will examine how depression, anxiety, and migraine run in families. It will help in defining the risk factors for physical, mental, and health problems-as well as define ways that those problems may be prevented and treated. A broad range of ages among family members will be included to evaluate the patterns of how these disorders are expressed throughout people's lives. Children of all ages will be included, and those ages 8 to 17 will be interviewed directly. Assessments will be c... Read More
Gender:
ALL
Ages:
Between 7 years and 120 years
Trial Updated:
01/18/2025
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland
Conditions: Mood Disorders, Sleep Disorders, Migraine
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Recruiting
To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.
Gender:
ALL
Ages:
Between 12 years and 17 years
Trial Updated:
12/09/2024
Locations: University of Maryland, Baltimore, Maryland
Conditions: Chronic Migraine in Children
Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
Recruiting
This study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treatment of migraine.
Gender:
ALL
Ages:
Between 18 years and 64 years
Trial Updated:
11/20/2024
Locations: Velocity Clinical Research, Rockville, Rockville, Maryland
Conditions: Migraine